146 related articles for article (PubMed ID: 2488183)
1. Pharmacokinetics of aztreonam administered i.p. in continuous ambulatory peritoneal dialysis (CAPD) patients.
Nikolaidis P; Dombros N; Alexiou P; Balaskas E; Tourkantonis A
Perit Dial Int; 1989; 9(1):57-9. PubMed ID: 2488183
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of once daily intra-peritoneal aztreonam and vancomycin in the treatment of CAPD peritonitis.
Brown J; Altmann P; Cunningham J; Shaw E; Marsh F
J Antimicrob Chemother; 1990 Jan; 25(1):141-7. PubMed ID: 2318749
[TBL] [Abstract][Full Text] [Related]
3. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
Fuiano G; Sepe V; Viscione M; Nani E; Conte G
Perit Dial Int; 1989; 9(4):273-5. PubMed ID: 2488380
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N
Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
[TBL] [Abstract][Full Text] [Related]
7. Single- and multiple-dose kinetics of ofloxacin in patients on continuous ambulatory peritoneal dialysis (CAPD).
Passlick J; Wonner R; Keller E; Essers L; Grabensee B
Perit Dial Int; 1989; 9(4):267-72. PubMed ID: 2488379
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
[TBL] [Abstract][Full Text] [Related]
9. Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis.
Brouard RJ; Kapusnik JE; Gambertoglio JG; Schoenfeld PY; Sachdeva M; Freel K; Tozer TN
Clin Pharmacol Ther; 1989 Jun; 45(6):674-81. PubMed ID: 2525081
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis.
Stamatiadis D; Papaioannou MG; Giamarellos-Bourboulis EJ; Marinaki S; Giamarellou H; Stathakis CP
Perit Dial Int; 2003; 23(2):127-31. PubMed ID: 12713078
[TBL] [Abstract][Full Text] [Related]
11. Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis.
Shah GM; Winer RL; Krasny HC
Am J Kidney Dis; 1986 Jun; 7(6):507-10. PubMed ID: 3717158
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
Burgess DS; Summers KK; Hardin TC
Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
[TBL] [Abstract][Full Text] [Related]
13. Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nikolaidis P; Walker SE; Dombros N; Tourkantonis A; Paton TW; Oreopoulos DG
Perit Dial Int; 1991; 11(1):59-63. PubMed ID: 2049424
[TBL] [Abstract][Full Text] [Related]
14. Amikacin pharmacokinetics during continuous ambulatory peritoneal dialysis.
Smeltzer BD; Schwartzman MS; Bertino JS
Antimicrob Agents Chemother; 1988 Feb; 32(2):236-40. PubMed ID: 3364945
[TBL] [Abstract][Full Text] [Related]
15. Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations.
Keller E; Reetze P; Schollmeyer P
Clin Pharmacokinet; 1990 Feb; 18(2):104-17. PubMed ID: 2180611
[TBL] [Abstract][Full Text] [Related]
16. Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis.
Veys N; Lameire N; Malerczyk V; Lehr KH; Rosenkranz B; Ringoir S
Clin Pharmacol Ther; 1993 Oct; 54(4):395-401. PubMed ID: 8222482
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of flecainide in a patient undergoing continuous ambulatory peritoneal dialysis.
Bailie GR; Waldek S
J Clin Pharm Ther; 1988 Apr; 13(2):121-4. PubMed ID: 3134365
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of single-dose rosiglitazone in chronic ambulatory peritoneal dialysis patients.
Aramwit P; Supasyndh O; Sriboonruang T
J Clin Pharm Ther; 2008 Dec; 33(6):685-90. PubMed ID: 19138247
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis.
Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G; Bonati M
Eur J Clin Pharmacol; 1986; 31(4):501-4. PubMed ID: 2949981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]